Researchers investigated the potential association between plasma apolipoprotein M (APOM) levels and the risk of adverse ...
Ozanimod (RPC1063) – a once-a-day pill also used in the treatment of multiple sclerosis – is a sphingosine-1-phosphate (S1P) receptor agonist that reduces the number of white blood cells ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback